RUA Life Sciences plc (AIM:RUA)
London · Delayed Price · Currency is GBP · Price in GBX 13.91
-0.34 (-2.39%)
Feb 13, 2026, 3:02 PM GMT
RUA Life Sciences Market Cap
RUA Life Sciences has a market cap or net worth of 8.84 million as of February 13, 2026. Its market cap has increased by 11.76% in one year.
Market Cap
8.84M
Enterprise Value
6.43M
Revenue
4.11M
Ranking
n/a
PE Ratio
8,843.59
Stock Price
13.91
Market Cap Chart
Since February 26, 1997, RUA Life Sciences's market cap has decreased from 23.82M to 8.84M, a decrease of -62.88%. That is a compound annual growth rate of -3.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 8.84M | 1.79% |
| Dec 31, 2025 | 8.69M | 27.27% |
| Dec 31, 2024 | 6.83M | 11.68% |
| Dec 29, 2023 | 6.11M | -43.19% |
| Dec 30, 2022 | 10.76M | -35.33% |
| Dec 31, 2021 | 16.64M | -50.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 231.18B |
| GSK plc | 85.92B |
| Haleon | 36.22B |
| Smith & Nephew | 11.10B |
| genedrive | 11.07M |
| Verici Dx | 10.22M |
| Genflow Biosciences | 9.38M |
| IXICO | 8.11M |